NeuroXess
Developer of implantable brain-computer interfaces.
About
NeuroXess is a startup focused on developing implantable brain-computer interfaces (BCIs). The company is part of China's rapidly advancing BCI industry, aiming to commercialize technologies that allow for direct, high-bandwidth connections between the human brain and AI. Their focus is on invasive electrophysiological BCIs, which involve implanting electrodes in the brain for precise neuron-level signals, though this approach carries surgical risks.
Similar companies
A neurotechnology company developing implantable Brain-Computer Interfaces.
Shares Neurotechnology, Artificial Intelligence
NeuroTech company developing therapies to restore movement and independence for people with spinal cord injuries.
Shares Neurotechnology
Noninvasive ultrasound BCI startup
Shares Biotech & Health, Artificial Intelligence
Deep-tech startup building a next-generation wearable for elite athletes to measure physiological and neurological metrics.
Shares Biotech & Health
Intero Biosystems develops human intestinal organoid platforms for drug discovery, aiming to improve preclinical testing and reduce animal reliance.
Shares Biotech & Health
Developing ultra-high bandwidth brain-machine interfaces to connect humans and computers.
Shares Neurotechnology
Key facts
- Headquarters
- China
- Business model
- B2B
Public record
SEC filings, insider activity, nonprofit links and pay benchmarks for NeuroXess
